2026年11月3日星期二
M
Catatan Universal
Berita Kilat Global
Mitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaAI dubbing to help Japanese companies expand global outreach— 日经 Nikkei AsiaIndonesia GDP, US midterm elections, Hong Kong financial summit— 日经 Nikkei AsiaPakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaVietnam solar success prompts rethink of power pricing— 日经 Nikkei AsiaGlobal legal body opens Hong Kong office, boosts city's law hub push— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaAI dubbing to help Japanese companies expand global outreach— 日经 Nikkei AsiaIndonesia GDP, US midterm elections, Hong Kong financial summit— 日经 Nikkei AsiaPakistan refineries report 1,860% jump in profit amid war windfall— 日经 Nikkei AsiaAfter US midterms, democracy will face test of ability to self-correct— 日经 Nikkei AsiaVietnam solar success prompts rethink of power pricing— 日经 Nikkei AsiaGlobal legal body opens Hong Kong office, boosts city's law hub push— 日经 Nikkei Asia

Two year randomised trial of twice versus once daily 0.01% atropine for childhood myopia control with real world extension

Sumber Nature 医学研究19 jam lalu
Ringkasan konten

Situs ini hanya menyediakan indeks judul dan ringkasan, konten lengkap dan hak cipta sepenuhnya milik penerbit asli, silakan klik tautan asli untuk membaca.

Buka artikel asli
Saluran terkait
Kesehatan
Wilayah terkait
Perspektif global
Bahasa asli
English
Nomor entri
health-1c715de0

Comments 0 comments

No comments yet. Be the first.

Two year randomised trial of twice versus once daily 0.01% atropine for childhood myopia control with real world extension · Catatan Universal